Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

CENTESSA PHARMACEUTICALS PLC SPONSORED ADS (CNTA)

154 + Investors. Track Smart Money conviction in CNTA. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +18
Streak
2Q ▲
Buyers last Q
55%

Smart Money Signals — CNTA

Based on 144 hedge funds · latest filing: 2025 Q4 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds added CNTA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
144 hedge funds hold CNTA right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +31% more funds vs a year ago

fund count last 6Q
+34 new funds entered over the past year (+31% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟡

Slight buying edge — 55% buying

90 buying73 selling
Last quarter: 90 funds bought or added vs 73 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
📈

More new buyers each quarter (+16 vs last Q)

new funds entering per quarter
Funds opening a new CNTA position: 34 → 19 → 25 → 41. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
📌

Mixed — 31% long-term, 38% new

■ 31% conviction (2yr+) ■ 31% medium ■ 38% new
Of the 144 current holders: 45 (31%) held >2 years, 45 held 1–2 years, and 54 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
💎

Buying through price weakness — shares +11%, value -51%

Value
-50%
Shares
+10%
Last quarter: funds added +11% more shares while total portfolio value only changed -51%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
📈

Growing discovery — still being found

24 → 34 → 19 → 25 → 41 new funds/Q
New funds entering each quarter: 34 → 19 → 25 → 41. A growing number of institutions are discovering CNTA each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
📊

Mixed cohorts — 36% veterans, 44% new entrants

■ 36% veterans ■ 19% 1-2yr ■ 44% new
Of 154 current holders: 56 (36%) held 2+ years, 30 held 1–2 years, 68 (44%) entered in the past year. Balanced distribution — some institutional memory, some recent momentum buyers.
📋

Smaller funds dominant — 16% AUM from top-100

16% from top-100 AUM funds
21 of 144 holders rank in the top 100 by AUM, but together hold only 16% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
4.2
out of 10
Moderate Exit Risk
Exit risk score 4.2/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — CNTA

In 2025 Q4, 90 hedge funds were net buyers of CNTA (41 opened a new position, 49 added to an existing one), while 73 reduced or exited (50 trimmed, 23 sold completely) — a 55% buyer ratio, indicating a slight buying edge. Net buying has persisted for two consecutive quarters, a positive momentum signal. Net fund flow last quarter: +18 funds (more new holders than closures). Total institutional holders: 144.

Hedge Fund Ownership: CNTA

How many hedge funds hold CNTA — quarterly history vs. share price
Quarterly hedge fund ownership of CNTA vs. share price

Market Analysis: CNTA

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: CNTA

Healthcare Biotechnology

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

15 top-rated funds 6 high-conviction
Consensus
5.2
/ 10
breadth
×
Elite
4.9
/ 10
conviction
Hedge Fund Positioning: CNTA
2026 Q1 Stats Unlock in 6 days 154 + Investors

Track Smart Money conviction in CNTA. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2025 Q4) Prior (2025 Q3) Change
Funds Holding 154 138 11.59%
13F Shares 144M 131M 10.62%
Total Value $3.51B $7.15B -50.88%
New Positions 42 26 +16
Increased Positions 61 47 +14
Closed Positions 24 18 +6
Reduced Positions 65 62 +3
Total Calls 7 9 -22.22%
Total Puts 4 7 -42.86%
PUT/CALL Ratio 0.57 0.78 Bullish

Statistics: CNTA

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

154 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in CNTA. Verified SEC 13F-HR filings.

Top 25 institutional holders of CNTA — 2025 Q4 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Medicxi Ventures Management (Jersey) Ltd 80.76% 19,963,157 $792.9M
2 Spruce Street Capital LP 4.68% 489,849 $19.5M
3 HighMark Wealth Management LLC 3.83% 236,785 $9.4M
4 Affinity Asset Advisors, LLC 2.87% 1,400,000 $55.6M
5 ALPINE ASSOCIATES MANAGEMENT INC. 2.03% 865,500 $34.4M
6 SILVERARC CAPITAL MANAGEMENT, LLC 1.89% 466,345 $18.5M
7 PLATINUM INVESTMENT MANAGEMENT LTD 1.38% 137,741 $5.5M
8 Siren, L.L.C. 1.16% 1,053,464 $41.8M
9 Knott David M Jr 0.92% 39,000 $1.5M
10 Caitong International Asset Management Co., Ltd 0.69% 93,685 $3.7M
11 Yakira Capital Management, Inc. 0.28% 24,000 $953K
12 GLAZER CAPITAL, LLC 0.27% 325,001 $13K
13 FEDERATED HERMES, INC. 0.13% 2,049,439 $81.4M
14 JBF Capital, Inc. 0.12% 20,887 $830K
15 Virtus Investment Advisers, LLC 0.11% 10,286 $409K
16 Virtu Financial LLC 0.11% 67,775 $3K
17 ROYCE & ASSOCIATES LP 0.11% 278,064 $11.0M
18 Meridian Wealth Partners, LLC 0.10% 18,101 $719K
19 Bayforest Capital Ltd 0.09% 1,947 $77K
20 Y-Intercept (Hong Kong) Ltd 0.07% 96,367 $3.8M
21 FOX RUN MANAGEMENT, L.L.C. 0.07% 14,913 $411K
22 China Universal Asset Management Co., Ltd. 0.06% 21,225 $843K
23 GABELLI & Co INVESTMENT ADVISERS, INC. 0.06% 9,400 $373K
24 Empirical Asset Management, LLC 0.05% 5,083 $202K
25 AXQ CAPITAL, LP 0.04% 8,303 $330K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — CENTESSA PHARMACEUTICALS PLC SPONSORED ADS (CNTA)

What does the Smart Money Trend signal show for CNTA?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added CNTA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for CNTA?

Slight buying edge — 55% buying: Last quarter: 90 funds bought or added vs 73 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for CNTA holders?

Smaller funds dominant — 16% AUM from top-100: 21 of 144 holders rank in the top 100 by AUM, but together hold only 16% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held CNTA?

Mixed — 31% long-term, 38% new: Of the 144 current holders: 45 (31%) held >2 years, 45 held 1–2 years, and 54 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.